MEI Pharma Gelecekteki Büyüme
Future kriter kontrolleri 0/6
MEI Pharma's revenue and earnings are forecast to decline at 26.2% and 35.5% per annum respectively while EPS is expected to decline by 22.8% per annum.
Anahtar bilgiler
-35.5%
Kazanç büyüme oranı
-22.8%
EPS büyüme oranı
Biotechs kazanç büyümesi | 27.1% |
Gelir büyüme oranı | -26.2% |
Gelecekteki özkaynak getirisi | n/a |
Analist kapsamı | Low |
Son güncelleme | 23 Jul 2024 |
Gelecekteki son büyüme güncellemeleri
Recent updates
New Forecasts: Here's What Analysts Think The Future Holds For MEI Pharma, Inc. (NASDAQ:MEIP)
Feb 17Increases to CEO Compensation Might Be Put On Hold For Now at MEI Pharma, Inc. (NASDAQ:MEIP)
Dec 30Need To Know: Analysts Are Much More Bullish On MEI Pharma, Inc. (NASDAQ:MEIP)
Nov 19We're Hopeful That MEI Pharma (NASDAQ:MEIP) Will Use Its Cash Wisely
May 18Need To Know: The Consensus Just Cut Its MEI Pharma, Inc. (NASDAQ:MEIP) Estimates For 2022
Mar 26Newsflash: MEI Pharma, Inc. (NASDAQ:MEIP) Analysts Have Been Trimming Their Revenue Forecasts
Feb 12MEI Pharma: Another PI3K Delta Progressing To The FDA
Feb 01Need To Know: Analysts Just Made A Substantial Cut To Their MEI Pharma, Inc. (NASDAQ:MEIP) Estimates
Dec 02We're Not Very Worried About MEI Pharma's (NASDAQ:MEIP) Cash Burn Rate
Nov 04MEI Pharma EPS misses by $0.12, misses on revenue
May 06MEI Pharma promotes Richard Ghalie to chief medical officer
Apr 30MEI Pharma shares rise 4% as Wells Fargo says voruciclib undervalued
Apr 26The Independent Non-Executive Director of MEI Pharma, Inc. (NASDAQ:MEIP), Frederick Driscoll, Just Sold 40% Of Their Holding
Feb 25New Forecasts: Here's What Analysts Think The Future Holds For MEI Pharma, Inc. (NASDAQ:MEIP)
Feb 11Kazanç ve Gelir Büyüme Tahminleri
Tarih | Gelir | Kazançlar | Serbest Nakit Akışı | Faaliyetlerden Nakit | Avg. Analist Sayısı |
---|---|---|---|---|---|
6/30/2027 | 25 | -31 | N/A | N/A | 1 |
6/30/2026 | 25 | -26 | N/A | N/A | 1 |
6/30/2025 | 6 | -40 | N/A | N/A | 2 |
6/30/2024 | 65 | 18 | -50 | -50 | N/A |
3/31/2024 | 67 | 26 | -44 | -44 | N/A |
12/31/2023 | 73 | 20 | -53 | -53 | N/A |
9/30/2023 | 105 | 41 | -56 | -56 | N/A |
6/30/2023 | 49 | -32 | -53 | -52 | N/A |
3/31/2023 | 59 | -38 | -57 | -57 | N/A |
12/31/2022 | 63 | -31 | -62 | -62 | N/A |
9/30/2022 | 42 | -54 | -56 | -56 | N/A |
6/30/2022 | 41 | -54 | -49 | -49 | N/A |
3/31/2022 | 37 | -47 | -45 | -44 | N/A |
12/31/2021 | 35 | -64 | -43 | -43 | N/A |
9/30/2021 | 36 | -60 | -35 | -35 | N/A |
6/30/2021 | 35 | -41 | -33 | -32 | N/A |
3/31/2021 | 52 | -53 | 48 | 48 | N/A |
12/31/2020 | 45 | -31 | 52 | 54 | N/A |
9/30/2020 | 33 | -43 | 42 | 43 | N/A |
6/30/2020 | 28 | -47 | 33 | 34 | N/A |
3/31/2020 | 5 | -24 | -44 | -43 | N/A |
12/31/2019 | 5 | -38 | -44 | -44 | N/A |
9/30/2019 | 6 | -5 | -31 | -31 | N/A |
6/30/2019 | 5 | -17 | -30 | -29 | N/A |
3/31/2019 | 4 | -39 | -25 | -25 | N/A |
12/31/2018 | 4 | -28 | -20 | -20 | N/A |
9/30/2018 | 2 | -46 | -27 | -27 | N/A |
6/30/2018 | 2 | -40 | -21 | -21 | N/A |
3/31/2018 | 2 | -25 | N/A | -21 | N/A |
12/31/2017 | 6 | -20 | N/A | -13 | N/A |
9/30/2017 | 22 | -2 | N/A | -12 | N/A |
6/30/2017 | 23 | 3 | N/A | 3 | N/A |
3/31/2017 | 23 | 1 | N/A | 3 | N/A |
12/31/2016 | 18 | -4 | N/A | -3 | N/A |
9/30/2016 | 1 | -21 | N/A | -3 | N/A |
6/30/2016 | N/A | -21 | N/A | -18 | N/A |
3/31/2016 | N/A | -21 | N/A | -21 | N/A |
12/31/2015 | N/A | -24 | N/A | -25 | N/A |
9/30/2015 | N/A | -28 | N/A | -27 | N/A |
6/30/2015 | N/A | -33 | N/A | -28 | N/A |
3/31/2015 | N/A | -36 | N/A | -27 | N/A |
12/31/2014 | N/A | -34 | N/A | -24 | N/A |
9/30/2014 | N/A | -31 | N/A | -22 | N/A |
6/30/2014 | N/A | -27 | N/A | -19 | N/A |
3/31/2014 | N/A | -22 | N/A | -16 | N/A |
Analist Gelecek Büyüme Tahminleri
Kazançlar ve Tasarruf Oranları: MEIP's earnings are forecast to decline over the next 3 years (-35.5% per year).
Kazançlar ve Piyasa: MEIP's earnings are forecast to decline over the next 3 years (-35.5% per year).
Yüksek Büyüme Kazançları: MEIP's earnings are forecast to decline over the next 3 years.
Gelir ve Pazar: MEIP's revenue is expected to decline over the next 3 years (-26.2% per year).
Yüksek Büyüme Geliri: MEIP's revenue is forecast to decline over the next 3 years (-26.2% per year).
Hisse Başına Kazanç Büyüme Tahminleri
Gelecekteki Özkaynak Getirisi
Gelecekteki ROE: Insufficient data to determine if MEIP's Return on Equity is forecast to be high in 3 years time